These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23919252)

  • 1. Clinical relevance of the (S)-citalopram-omeprazole interaction in geriatric patients.
    Lozano R; Bibian C; Quilez RM; Gil J; Constante Y; Garcia-Arilla E
    Br J Clin Pharmacol; 2014 Jun; 77(6):1086-7. PubMed ID: 23919252
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B; Spectre G; Shai E; Lotan A; Ritter A; Al-Aieshy F; Malmström RE; Varon D; Alcalai R
    Pharmacotherapy; 2015 Feb; 35(2):140-7. PubMed ID: 25689244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis.
    Bykov K; Schneeweiss S; Glynn RJ; Mittleman MA; Bates DW; Gagne JJ
    Drug Saf; 2017 Oct; 40(10):923-932. PubMed ID: 28623527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-
    Cuypers ML; Chanteux H; Gillent E; Bonnaillie P; Saunders K; Beckers C; Delatour C; Dell'Aiera S; Ungell AL; Nicolaï J
    Drug Metab Dispos; 2020 Nov; 48(11):1121-1128. PubMed ID: 32839278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U; Gram LF; Vistisen K; Loft S; Poulsen HE; Brøsen K
    Eur J Clin Pharmacol; 1996; 51(1):73-8. PubMed ID: 8880055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers.
    Rocha A; Coelho EB; Sampaio SA; Lanchote VL
    Br J Clin Pharmacol; 2010 Jul; 70(1):43-51. PubMed ID: 20642546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline.
    Gjestad C; Westin AA; Skogvoll E; Spigset O
    Ther Drug Monit; 2015 Feb; 37(1):90-7. PubMed ID: 24887634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes.
    Kobayashi K; Yamamoto T; Chiba K; Tani M; Ishizaki T; Kuroiwa Y
    Br J Clin Pharmacol; 1995 Nov; 40(5):481-5. PubMed ID: 8703653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors.
    Dekeyne A; Denorme B; Monneyron S; Millan MJ
    Neuropharmacology; 2000 Apr; 39(6):1114-7. PubMed ID: 10727723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment.
    Moeller O; Hetzel G; Rothermundt M; Michael N; Nyhuis PW; Suslow T; Arolt V; Erfurth A
    J Psychiatr Res; 2003; 37(3):261-2. PubMed ID: 12650745
    [No Abstract]   [Full Text] [Related]  

  • 12. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.
    von Moltke LL; Greenblatt DJ; Giancarlo GM; Granda BW; Harmatz JS; Shader RI
    Drug Metab Dispos; 2001 Aug; 29(8):1102-9. PubMed ID: 11454728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram.
    Eltayb A; Svensson TH; Ahlenius S
    Eur J Pharmacol; 2001 Jan; 411(3):275-7. PubMed ID: 11164384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of citalopram on serotonin neurotransmission.
    Selvaraj S; Faulkner P; Mouchlianitis E; Roiser JP; Howes O
    Mol Psychiatry; 2012 Dec; 17(12):1143. PubMed ID: 23168914
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of citalopram selective serotonin reuptake inhibitor on circadian rhytms of excretory function of the kidneys].
    Kushnir IH; Kokoshchuk HI
    Fiziol Zh (1994); 2009; 55(3):125-7. PubMed ID: 19526865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perhexiline toxicity related to citalopram use.
    Nyfort-Hansen K
    Med J Aust; 2002 Jun; 176(11):560-1. PubMed ID: 12064991
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line: an in vitro study.
    Salai M; Somjen D; Gigi R; Yakobson O; Katzburg S; Dolkart O
    Bone Joint J; 2013 Nov; 95-B(11):1575-80. PubMed ID: 24151282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing.
    Inoue T; Hashimoto S; Tsuchiya K; Izumi T; Ohmori T; Koyama T
    Eur J Pharmacol; 1996 Sep; 311(1):1-6. PubMed ID: 8884229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S
    Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.